Menu HOME Renal Care Hospital Products PharmaPackaging Cardiopulmonary Diabetes Care Enzymes IVD Nipro Europe Group Companies HOME About us News Contact us Careers Renal Care Pharma- Packaging Hospital Products Enzymes and IVD Cardio- pulmonary Diabetes Care ERA-EDTA 2017 Madrid symposium review In the lunch symposium entitled: “New biocompatible haemodiafiltration (HDF) membrane to enable maximum substitution for sensitive patients”, held during the EDTA 2017, Nipro introduced their new semi-natural asymmetric membrane, SOLACEA. The SOLACEA is a membrane, well equipped to perform high volume convective therapies, like high volume online HDF, while maintaining the good biocompatible characteristics to treat sensitive patients. In this symposium, Prof. R. Selgas introduced the reason for the need of good alternative membranes for sensitive patients. However at this moment, most of these alternative membranes on the market are not capable to sustain high convective therapies (> 20 l/session). The new SOLACEA membrane is ideal for high volume HDF without major albumin losses, as highlighted by one of the key opinion leaders in the field of high volume HDF, Dr. F. Maduell. The excellent biocompatibility of the SOLACEA was addressed by the key opinion leader, Dr. T. Tomo, who showed that the SOLACEA induced the lowest amount of micro-inflammation in high volume HDF therapy. Combined, these talks emphasize the added value of the SOLACEA on the current dialyzer market. The document is available online via the following link:http://emjreviews.com/journals/emj-nephrology-5-1-2017/ or alternatively you can go to the EMJ Nephrology site: http://emjreviews.com/journals/ and click on the EMJ Nephrology 5.1 2017 link. ERA-EDTA Thanks for your vists at our booth in Madrid. We are looking forward to see you again next year in Copenhagen. Don’t just find a job,find a career @ Nipro Zaventem, Juli 2016 We are continually seeking talented individuals at all levels. Nipro offers excellent opportunities within sales, marketing, finance and technical departments for all of its European offices. Have a look on our careers page to find out the latest possibilities. news archive » Pursuing eco-friendly business approach Enhancing environmental awareness Nipro recognizes the importance of environmental preservation and acts conscientiously. Active involvement in environmental issues is an essential part of corporate activity. We keep an eye on our potential impact on the global environment not in the manufacturing process alone, but in all aspects of our business activities. In our efforts to preserve and improve the environment, we pursue efficient use of resources and energy, reduction of waste and emissions, assessment and mitigation of the impact of our products and production process on the environment, and development and use of environmental technologies. We take swift and appropriate action to alleviate any adverse impact or potential impact on the environment and to improve the environment. We also cooperate with the local community in environmental activities, and provide fair and appropriate information. To help reduce environmental burden we promote recycling, lights-off and other conservation activities that can easily be done on a daily basis. Promoting environmental management Nipro promotes various activities at its offices and factories to reduce burdens on the global environment. Recognizing environmental conservation as a key issue, each and every worker is actively involved in eco-friendly initiatives, such as conservation and reuse of resources, and energy-saving campaigns for lighting and air-conditioning systems. Paperless office (digitizing documents for internal use, eliminating meeting handouts etc.) Reduction of paper and other waste Recycling of resources at factories Energy conservation at offices (maintaining air-conditioning pre-set temperatures at 28°C for cooling and 20°C for heating) Ensuring waste separation and recycling About Us Mission Quality & Safety Factories Branches Research & Development Mission In each business area of Nipro Corporation, priority is focused on building long-term partnerships with each customer. This is accomplished by providing superior quality and value throughout the business in addition to listening to customer needs and translating those needs into specific products and services. Nipro Europe constantly thrives to create and offer safe, high-quality products ensuring a better quality of life. Being recognized as a worldwide leading brand vital to the medical field of artificial organs, regenerative medicines and other medical devices, we continue to strive for growth by becoming our customer’s first choice. Through people… …we offer an organization that is attractive and challenging. We strive for operational excellence through an experienced and talented employee base. We empower and provide our people with the resources needed to develop professionally, improving their skills, resulting in a dedicated team. Through our products… …we manage a portfolio that is focused on customer and market demand. We always strive to expand in new and current markets with innovative products and applications. By continuously increasing our positioning efforts, we enlarge our brand name recognition. Through processes …we are a sales and marketing-focused organization, committed to continuously advancing our efficiency and improving our work to provide superior products and services. Kurt Van Dal CEO/president Quality & Safety Nipro is dedicated to improve the quality and safety of healthcare. Medical devices are now a pervasive part of modern medical care. They are in many cases associated with quality of care. Healthcare worker and patient safety are key strategies for healthcare providers. Nipro assists providers to meet this challenge by supplying a developing portfolio of next generation safety medical products aimed at reducing the risk of needlestick injuries and associated infections. Nipro’s quality system is focused on satisfying critical specifications, continuously improving all products and complying with regulatory requirements. Regulatory services include 510(k) and technical file preparation and assistance with CE Marking. Nipro continuously move products to higher levels of quality and reliability. “Our customers expect the highest quality products and materials, made for their specific needs, and delivered in a short time frame.” Factories Nipro Pure Water Werner-von-Siemens-Str. 2-6 76646 Bruchsal – Germany +49 7251 / 32 19 78 10 info@nipropurewater.com Nipro Pure Water (NPW) manufacturers water treatment equipment and specialized furnishing for dialysis centers. NPW is stationed in Germany. Following is a list of countries where NPW has installed successfully reverse osmosis systems. Eurasia: Germany, Belgium, France, Italy, Spain, Poland, Lithuania, Ukraine, UK, Bosnia, Iran, Thailand and Russia Africa: Senegal, Mauritania, Ghana, Libya, Nigeria, Algeria, Kenya, Rwanda, South Africa and Morocco South America: Suriname and Peru Nipro Renal Solutions Pol.Ind. TUMSA – nave 31 25230 Mollerusa (Lleida) Spain +34 973 710 758 info@niprorenalsolutions.com www.niprorenalsolutions.com Nipro Renal Solutions S.R.L was founded in Mollerussa, Spain in 1994. NRS specializes in the manufacture of concentrates for hemodialysis and is currently the leading producer of concentrates in Spain. Sustained growth over the last two decades has also positioned NRS in the international market; currently, NRS concentrates can be found in Europe, Asia, and Latin America. NRS strives to satisfy customers’ needs by providing optimized solutions for hemodialysis through a combination of talented staff and know-how. NRS’ R&D department is fully committed to deliver safe, innovative, and high- quality dialysis concentrates tailored to meet the market’s needs. NRS holds an EC certificate for medical devices in accordance with directive 93/42/CEE and produces European Pharmacopeia compliant products. NRS has a strict quality management policy and is compliant with regulatory standards of product and environmental safety. Furthermore, NRS’ quality management system is implemented in accordance with UNE-EN-ISO 9001 and EN-ISO-13485. Certificates can be obtained through the links below: ISO 13485 ISO 9001 Branches Nipro Europe – France Biopôle Clermont-Limagne 63 360 Saint Beauzire – France T: +33 473 33 41 00 F: +33 473 33 41 09 Nipro Europe – Netherlands Regus Business Center Verlengde Poolseweg 16 4818 CL Breda – Netherlands T: +31 (0)76 524 50 99 F: +31 (0)76 524 46 66 Nipro Europe – Poland Ul. Pańska 73 00-834 Warszawa – Poland T: +48 22 31 47 155 F: +48 22 31 47 152 Nipro Europe – Spain Poligono Los Frailes n° 93 y 94 – Daganzo 28814 Madrid – Spain T: +34 91 884 5531 F: +34 91 878 2840 Nipro Europe – Russia 12 Krasnopresnenskaya Nab. Office 1408, entrance 6 123610 Moscow – Russia T: +7 495 258 1364 F: +7 495 258 1367 Nipro Europe – Italy Centro Direzionale Milanofiori Strada 1 – Palazzo F/1 20090 Assago (Milano) – Italy T: +39 02 57 50 00 57 F: +39 02 57 51 81 11 Nipro Austria GmbH Divischgasse 4 1210 Wien – Austria Nipro Senegal S.U.A.R.L. 27 Avenue Georges Pompidou Dakar – Senegal Nipro Nordics A.B. Stortorget 13B 211 22 Mälmo – Sweden T: +46 (0)40 60 61 250 F: +46 (0)40 60 61 255 Research & Development The Nipro Group promotes research and development of both medical equipment and pharmaceutical products. Our research and development focuses on cutting-edge technologies as well as trying to achieve higher quality and improved functionality with our existing products. We expect to commercialize one of our cutting-edge products, namely our nerve regeneration-assisting device, which uses our unique bio-absorbable materials, developed in-house. We have come close to developing a cell-culturing system thanks to our studies of stem cells in umbilical blood. In terms of artificial organs, our range of implanted ventricular-assist devices, developed in cooperation with an American company, are currently at the clinical testing stage in Japan. With regard to the development of new drugs and new formulation technologies, further to the commercialization of our powdered dialysis solutions based on a new and highly effective granulation technology, we plan to be the first company to commercialize a double-bag product for hemodiafiltration substitution fluids as well as selling various products such as pre-filled syringes for safety use, thereby contributing to the prevention of medical accidents. In this consolidated accounting year, the total cost of R&D activity was 4.8 billion yen (US$ 52.1 million). Careers Working @ Nipro Europe Don’t just find a job, find a career @ Nipro Nipro offers you the opportunity to join one of its four Business units and be part of a leading brand. Whether you are an Account Manager with Hospital Products, a Customer Services Representative at headquarters or a Clinical Support Specialist with Renal Care you will find a career with Nipro that will challenge your thinking, develop your professional skills and brings you into contact with people who share the same commitment to simplicity and service. We’re continually seeking talented individuals at all levels. Nipro offers excellent opportunities within sales, marketing, finance and technical departments for all of its European offices. Send your application letter with curriculum vitae to careers@nipro-europe.com and see how far your career can take you. Nipro Europe is committed to equal opportunity in employment, and is opposed to discrimination of employees or applicants for employment, on the grounds of race, religious beliefs, colour, nationality, sex, sexual orientation, marital/parental status, age, or disability. Opportunities Director Human Resources Germany Key Account Manager – PharmaPackaging (DACH-region) Contact Us Name* Email* Company* Country* Afghanistan Albania Algeria American Samoa Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Congo, Democratic Republic of the Congo, Republic of the Costa Rica Côte d'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France French Polynesia Gabon Gambia Georgia Germany Ghana Greece Greenland Grenada Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Northern Mariana Islands Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Sudan, South Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands, British Virgin Islands, U.S. Yemen Zambia Zimbabwe Phone Message Phone This field is for validation purposes and should be left unchanged.